GSK-100382

Study Sponsor: GSK

Study Title

Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of GSK Biologicals’ Combined Hepatitis A & B Vaccine, vs Separately Administered Monovalent Hepatitis A and Hepatitis B Vaccines

Medicine or Vaccine (generic name)

twinrix

Sponsor Identification Number

100382

Trial Registry Identification Number(#'s)

NCT00289731

Medical Condition

Hepatitis A; Hepatitis B

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=100382

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00289731

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The results of this study 100382 are summarised with studies 100383, 100384, and 100385 on the GSK Study Register. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

October 2014